Similar Search Results

Retail price regulation and innovation : reference pricing in the pharmaceutical industry

Bommier, Antoine (contributor); Jullien, Bruno (contributor) - 2006 - Rev.

Persistent link: https://www.econbiz.de/10003471087

The national regulation of pharmaceutical markets and the timing of new drug launches in Europe

Heuer, Alexander (contributor); Mejer, Malwina (contributor) - 2007

, pharmaceutical companies, by acting strategically, may further increase launch delays. -- pharmaceuticals ; regulation ; new chemical …

Persistent link: https://www.econbiz.de/10003471161

Price regulation and generic competition in the pharmaceutical market

Dalen, Dag Morten; Strøm, Steinar; Haabeth, Tonje - In: The European journal of health economics : HEPAC ; … 7 (2006) 3, pp. 208-214

Persistent link: https://www.econbiz.de/10003378742

Advertising, generic competition and price regulation in pharmaceutical markets

Königbauer, Ingrid - In: CESifo economic studies : CESifo, a joint initiative of … 52 (2006) 3, pp. 565-586

The effect of price regulation on generic market entry and welfare in the presence of (persuasive) advertising is analysed. An incumbent has the possibility to invest in advertising targeted at the physician. Advertising creates vertical product differentiation between brand-name drugs and its...

Persistent link: https://www.econbiz.de/10003379146

Retail price regulation and innovation : reference pricing in the pharmaceutical industry

Bardey, David; Bommier, Antoine; Jullien, Bruno - In: Journal of health economics 29 (2010) 2, pp. 303-316

Persistent link: https://www.econbiz.de/10003978602

Patentgeschützte Arzneimittel im Regulierungsdickicht des Arzneimittelmarktneuordnungsgesetzes

Jaeckel, Roger; Kunz, Angelika R. - In: Handbuch Market-Access : Marktzulassung ohne Nebenwirkungen, (pp. 239-250). 2011

Persistent link: https://www.econbiz.de/10008859748

Germany's struggle with prices for patent-protected drugs

Kifmann, Mathias; Neelsen, Sven - In: CESifo DICE report : journal for institutional comparisons 8 (2010) 3, pp. 43-52

Persistent link: https://www.econbiz.de/10008702709

Eliminating drug price differentials across government programmes in the USA

Chalkidou, Kalipso; Anderson, Gerard F.; Faden, Ruth - In: Health economics, policy and law 6 (2011) 1, pp. 43-64

Persistent link: https://www.econbiz.de/10008855856

Arzneimittelpreisbildung in Europa : Abwägung der Optionen

Mossialos, Elias; Brogan, David; Walley, Tom - In: Internationale Revue für soziale Sicherheit 59 (2006) 3, pp. 3-32

Persistent link: https://www.econbiz.de/10003381812

The cost of US pharmaceutical price regulation : a financial simulation model of R&D decisions

Abbott, Thomas A.; Vernon, John A. - In: Managerial and decision economics : MDE ; the … 28 (2007) 4/5, pp. 293-306

Persistent link: https://www.econbiz.de/10003543647